During the past decade, Inovio Biomedical Corporation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Inovio Biomedical Corporation" are "Head and Neck Cancer" (2 trials), "Cancer" (1 trials) and "Head Neck Cancer" (1 trials). Many other conditions were trialed in "Inovio Biomedical Corporation" in a lesser frequency.

Most popular intervention types in "Inovio Biomedical Corporation" are "Combination Product" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Medpulser Electroporation with Bleomycin" (2 trials), "MedPulser Electroporation with bleomycin" (1 trials), "Medpulser electroporation with Bleomycin" (1 trials), "Surgical Excision" (1 trials) and "Tumor surgical excision" (1 trials). Other intervention names were less common.

The vast majority of trials in "Inovio Biomedical Corporation" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Inovio Biomedical Corporation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Inovio Biomedical Corporation, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Inovio Biomedical Corporation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".